Delivery Order SPE2DB20D3304-SPE2DB24FW6F2

Award Date 5/29/24
Potential Completion Date 5/30/24
Potential Value $1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,147.40 Firm Fixed Price Delivery Order is for the supply of the ROTATEQ VACCINE 2ML product, with a period of performance through December 12, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...
This federal contract award is a delivery order valued at $2,428.01 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the ROTATEQ vaccine, a 2ml vaccine product, with a completion date of April 4, 2025. The contract utilizes a firm fixed-price pricing type and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
This federal contract award, valued at $34,497.93, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. The IDC, valued at up to $999,999,999.00, serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of...
This federal contract award from the Defense Logistics Agency (DLA) is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of the ROTATEQ vaccine in 2 milliliter volumes. The firm-fixed-price Delivery Order is valued at $2,131.20 and has a completion date of February 11, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as the...
This $2,605.24 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, for the supply of 4,565,164,820 units of the ROTATEQ vaccine. The order has a completion date of July 17, 2024 and is not set aside for any specific business type. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999 through...
This federal contract award, valued at $2,689.05, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ROTATEQ vaccine, a 2ml vaccine product, and is a firm fixed-price delivery order with a completion date of January 21, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award, valued at $1,300.85, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the ROTATEQ vaccine, a 2ML dose, with a completion date of July 9, 2024. This contract award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,630.29, is for the delivery of the ROTATEQ vaccine in 2 milliliter vials. This is a firm fixed-price delivery order contract with an ultimate completion date of December 10, 2024. The award is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was made by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,304.14, is for the delivery of the rotavirus vaccine ROTATEQ in 2 mL doses. This is a firm fixed-price delivery order contract with an ultimate completion date of October 10, 2024. The contract does not have a set-aside designation. Amerisourcebergen, through its extensive supply chain network, provides...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,033.24, is for the delivery of the ROTATEQ vaccine in 2 milliliter doses. It is a firm fixed price delivery order contract with a completion date of January 15, 2025. The contract was not set aside for any specific business category. AmerisourceBergen holds a significant Indefinite Delivery...
  • SPE2DB20D3304
    Indefinite Delivery Contract
  • SPE2DB20D3304-SPE2DB24FW6F2
    Delivery Order

This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,009.64 Delivery Order is for the supply of the ROTATEQ vaccine, a 2 mL dosage. The contract is a Firm Fixed Price arrangement with a completion date of May 30, 2024.

Amerisourcebergen Drug Corp is a major pharmaceutical distributor that has an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999.00 through December 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a wide range of pharmaceutical products and medical supplies to support the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024. This particular contract award was not set aside for any socioeconomic designation.

Generated 8/28/24, 11:39 AM